CSIMarket
 
Revolution Medicines Inc   (RVMD)
Other Ticker:  
 
 


The Biotechnology & Pharmaceuticals company has failed to become profitable in the wake of epic Surge in Revenues in the third quarter of 2022 earnings season

RVMD recorded third quarter of 2022 operating shortfall of $-76.533 millions

Published 2022-11-08T18:12:05+00:00
Goran Soko / CSIMarket.com Contributer

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons RVMD announced very solid Revenue growth of 204.814 % year on year to $3.36 millions in the fiscal three months ending September 30 2022, but increased a deficit per share at $-0.87.

from the preceding quarter advanced deficit from $-0.82 per share and Revenue Tumbled by -63.186 % from $9.12 millions.


For the third quarter of 2022 earnings season Revolution Medicines Inc realized net deficit of $-73.329 million, higher than $-52.940 million a year ago.


Revolution Medicines Inc is expected to report next financial recent numbers on February 27, 2023.


    Recently Reported Results
Tomography_(CAT)_scan_pd Haemonetics Corporation

Excellent result by the company in the third quarter of 2022 earnings season

HAE had astonishing third quarter of 2022 earnings season, where profit per share jumped by 42.22 % to $0.64 per share, followed by Revenue an increase of 17.528 % to $305.30 millions, compared with the prior year period.

factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

The output of the nation's factories, mines and utilities fell in October by -0.1 %

Fed reported declining U.S. Industrial production in October, as the demand for industrial goods softens.

server-90389_960_720 Liveramp Holdings Inc

Regardless of Strong Revenues Profitability not Reached by the Liveramp Holdings Inc in the most recent fiscal period

Although Liveramp Holdings Inc s' Revenues increased by 12.81 % from the corresponding reporting season a year prior to $158.62 millions in the most recent fiscal period, the Computer processing and cloud services company increased a loss per share at $-0.46 loss per share.

Production by industry

Capacity utilization by industry

glowing-2245832__340 Incyte Corporation

It was very robust behavior by Incyte Corporation in the financial three months ending December 31 2022

Incyte Corporation announced net profit per share of $0.13 and Revenue of $823.30 millions in the most recent fiscal period, company's income fell sharply $0.13 per share, versus $2.54 eps, earned in the same three months a previous year, although Incyte Corporation saw its Revenue rise by 7.4 % in the same period.

Production by industry

Capacity utilization by industry

chip_pd Power Integrations Inc

Significant EPS Contraction at the Semiconductors company in the most recent fiscal period

For the most recent fiscal period Power Integrations Inc net profit per share dropped by -39.5 % of $0.40 per share compare to $0.66 a year ago and profit plummeted by -50.02 % from $0.80 per share from the prior reporting period.

Revenues crumbled by -27.734 % to $124.77 millions from $172.65 millions in the same reporting period a year ago and sequentially Revenues fell by -22.132 % from $160.23 millions.

Production by industry

Capacity utilization by industry

Warehouse_By Cayco_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Retail Inventories

U.S. retail inventories rise in September

The retail inventories growth rate accelerated compare to the slow down in previous month, due to growing inventories at the car dealars.

workout_By_Nnu-12-22100541Tracy_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Productivity

Real Hourly Compensation continues to drop

Americans are earning less (inflation adjusted) per hour, despite the gain in productivity, as decline in manufacturing offset an increase in nonfarm business productivity.

Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Personal Income and Spending

U.S. incomes outpace spending in the November 2022

Americans turned thriftier in the November 2022, spending less and saving more, according to fresh government data.

Chips-Deluxe-Rainbow_pd The Hain Celestial Group Inc

Slight -4.766 %, Revenues slide at The Hain Celestial Group Inc all along the October to December 31 2022 span

For the fiscal period closing December 31 2022 The Hain Celestial Group Inc EPS dived by -63.64 % of $0.12 per share compare to $0.33 a year before and Income per Share soared by 50 % from $0.08 per share from the previous reporting period.

Revenues contracted by -4.766 % to $454.21 millions from $476.94 millions in the comparable reporting period a year before and sequentially Revenues advanced by 3.382 % from $439.35 millions.

Personal income and it's spending

Quarterly personal income

NYCSkylineBy_FASTILY_(Own_Work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg Pathward Financial Inc

Serious Revenues deterioration, at Pathward Financial Inc in the first quarter of 2022

In the first quarter of 2022 Commercial Banks company reported soft top and bottom-line, where net profit per share plummeted by -51 % and revenue by -11.366 % year on year. Revenue were to $140.06 millions in proportion to $158.02 millions eps at $0.98 compared to $2.00 in the fiscal period ending December 31 2021.

Personal income and it's spending

Quarterly personal income

BuySell_pd.jpg Stonex Group Inc

EPS deteriorated while Revenues improved significantly the Stonex Group Inc in the fiscal first quarter of 2022

Regardless of impressive Revenue advance of 1679.973 % year on year to $13.01 billions in the Dec 31 2022 report, Stonex Group Inc s' income turned positive at $3.62.

Personal income and it's spending

Quarterly personal income

Safe_By_Korzun_Andpey_(KoriAn)_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Riverview Bancorp Inc

A soft Revenues elevation at RVSB in the third quarter of 2022

Revenue elevation of 1.295 %, could not prevent income decline of -4 % in the fiscal interval ending December 31 2022, from comparable reporting season a year ago. Revenues were at $16.66 millions and eps at $0.24.

Personal income and it's spending

Quarterly personal income

Silage_windrows_and_two_tractors_2 Brightview Holdings Inc

In spite of Strong Revenues Profitability not Reached by the BV all along the first quarter of 2022

Although BVs' Revenues increased by 10.831 % from the similar financial reporting period a year prior to $655.90 millions in the most recent fiscal period, BV increased a deficit per share at $-0.20 deficit per share.

Personal income and it's spending

Quarterly personal income

Red_pill_wikipedia_By_FML_(Own_work)_[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]_via_Wikimedia_Commons Exelixis Inc

The Biotechnology & Pharmaceuticals company reported a modest performance, over the financial interval closing Dec 30 2022

For the fourth quarter of 2022 company slipped into deficit of $-0.09 per share compare to $0.29 a year prior and EPS fell from $0.23 per share from the prior reporting period.

Revenues sunk by -6.034 % to $423.92 millions from $451.14 millions in the comparable reporting period a year prior and sequentially Revenues surged by 2.958 % from $411.74 millions.

Personal income and it's spending

Quarterly personal income



Other RVMD's Earnings Reports

Revolution Medicines Inc reported third quarter 2022 earnings

Revolution Medicines Inc reported second quarter 2022 earnings

Revolution Medicines Inc reported first quarter 2022 earnings

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TRUU's Profile

Stock Price

TRUU's Financials

Business Description

Fundamentals

Charts & Quotes

TRUU's News

Suppliers

TRUU's Competitors

Customers & Markets

Economic Indicators

TRUU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071